文献速递消化道肿瘤与早癌消化内镜

基于临床危险因素(超越结直肠癌家族史)的个体化结直肠癌筛查

Individualized colorectal cancer screening based on the clinical risk factors: beyond family history of colorectal cancer.
PubMed 文献 · Gastrointest Endosc · 2018-03-03

本研究纳入34,658例无结直肠癌家族史者,按年龄、男性、吸烟、肥胖建立风险评分并分析进展期结直肠肿瘤(ACRN)患病率。评分≥2分者建议早期结肠镜,评分0~1分者粪便免疫化学检测(FIT)可作为合适初筛方式。

要点

  • 无结直肠癌家族史者中,年龄、男性、吸烟、肥胖为ACRN危险因素。
  • 男性、吸烟、肥胖分别赋1分、2分、1分;评分≥2分者ACRN患病率更高。
  • 评分≥2分(吸烟史或肥胖男性)可建议早期结肠镜;评分0~1分者FIT可作为合适初筛。

核心结论

  • 若临床风险评分≥2分(有吸烟史或肥胖男性),即使无结直肠癌家族史,也可建议早期结肠镜。
  • 若临床风险评分为0~1分,FIT可能是平均风险个体合适的初筛方式。

研究设计与样本

  • 纳入无结直肠癌家族史、接受筛查结肠镜和FIT的参与者,共34,658例。
  • 采用逻辑回归模型识别ACRN临床危险因素,并依据回归系数为每个相关因素赋分。

主要发现

  • 年龄、男性、吸烟、肥胖被识别为ACRN危险因素;男性、吸烟、肥胖分别赋1分、2分、1分。
  • 50~51岁人群中,风险评分0、1、≥2分者ACRN患病率分别为1.4%、1.6%、2.9%。
  • ≥66岁人群中,风险评分0、1、≥2分者ACRN患病率分别为3.1%、5.5%、7.5%。
  • FIT阳性者中,50~51岁和≥66岁人群ACRN患病率分别为11.0%和21.2%。
  • FIT阴性且风险评分≥2分者中,50~51岁和≥66岁人群ACRN患病率分别为2.5%和6.0%。

临床怎么用

  • 作者建议:临床风险评分≥2分(有吸烟史或肥胖男性)者可推荐早期结肠镜,即使无结直肠癌家族史。
  • 作者建议:临床风险评分0~1分的平均风险个体,FIT可作为合适的初筛方式。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Individuals without a family history of colorectal cancer (CRC) are screened uniformly despite interpersonal risk. To assess individual risk, we examined the age-specific prevalence of advanced colorectal neoplasia (ACRN) according to clinical risk factors and fecal immunochemical test (FIT) results. METHODS: Participants without a family history of CRC who underwent screening colonoscopies and FITs were included. Clinical risk factors for ACRN were identified by using a logistic regression model. Point scores were assigned to each associated factor based on a regression coefficient. RESULTS: A total of 34,658 participants were included. Age, male sex, smoking, and obesity were identified as risk factors. One-, 2-, and 1-point scores were assigned to male sex, smoking, and obesity, respectively. The prevalence of ACRN in individuals with 0, 1, and ≥2 risk score points was 1.4%, 1.6%, and 2.9% among those aged 50 to 51 years and 3.1%, 5.5%, and 7.5% among those aged ≥66 years, respectively. Among FIT-positive individuals, the prevalence of ACRN was 11.0% and 21.2% in those aged between 50 and 51 years and those aged ≥66 years, respectively. Among FIT-negative individuals with ≥2 risk score points, the prevalence of ACRN was 2.5% and 6.0% among those aged 50 to 51 years and those aged ≥66 years, respectively. CONCLUSION: If the clinical risk score is ≥2 points (persons with smoking history or obese men), early colonoscopy may be recommended, even with no family history of CRC. Additionally, FIT may be an appropriate initial screening modality for average-risk individuals if the clinical risk score is 0 to 1.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Park CH, Kim NH, Park JH, et al. Individualized colorectal cancer screening based on the clinical risk factors: beyond family history of colorectal cancer. Gastrointest Endosc. 2018. PMID: 29510145. doi:10.1016/j.gie.2018.02.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。